"Creatine Kinase, MB Form" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An isoenzyme of creatine kinase found in the CARDIAC MUSCLE.
| Descriptor ID |
D052279
|
| MeSH Number(s) |
D08.811.913.696.640.150.625
|
| Concept/Terms |
Creatine Kinase, MB Form- Creatine Kinase, MB Form
- Myocardial Creatine Kinase
- Creatine Kinase, Myocardial
- Kinase, Myocardial Creatine
- Isoenzyme CPK-MB
- CPK-MB, Isoenzyme
- Isoenzyme CPK MB
- MB Creatine Kinase
- Creatine Kinase, MB
- Kinase, MB Creatine
|
Below are MeSH descriptors whose meaning is more general than "Creatine Kinase, MB Form".
Below are MeSH descriptors whose meaning is more specific than "Creatine Kinase, MB Form".
This graph shows the total number of publications written about "Creatine Kinase, MB Form" by people in this website by year, and whether "Creatine Kinase, MB Form" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 4 | 4 |
| 2003 | 0 | 3 | 3 |
| 2005 | 0 | 1 | 1 |
| 2006 | 2 | 0 | 2 |
| 2007 | 1 | 0 | 1 |
| 2008 | 0 | 2 | 2 |
| 2009 | 0 | 2 | 2 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 1 | 2 |
| 2017 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Creatine Kinase, MB Form" by people in Profiles.
-
Impact of Periprocedural Myocardial Biomarker Elevation on Mortality Following Elective Percutaneous Coronary Intervention. JACC Cardiovasc Interv. 2019 10 14; 12(19):1954-1962.
-
Trends in Use of Biomarker Protocols for the Evaluation of Possible Myocardial Infarction. J Am Heart Assoc. 2017 Sep 22; 6(9).
-
Biomarkers and mortality in severe Chagas cardiomyopathy. Glob Heart. 2015 Sep; 10(3):173-80.
-
Clinical and Functional Outcomes Associated With Myocardial Injury After Transfemoral and Transapical Transcatheter Aortic Valve Replacement: A Subanalysis From the PARTNER Trial (Placement of Aortic Transcatheter Valves). JACC Cardiovasc Interv. 2015 Sep; 8(11):1468-1479.
-
Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial. Eur Heart J. 2014 Oct 01; 35(37):2516-23.
-
Elevated CK-MB with a normal troponin does not predict 30-day adverse cardiac events in emergency department chest pain observation unit patients. Crit Pathw Cardiol. 2014 Mar; 13(1):14-9.
-
Differential release kinetics of cardiac biomarkers in off-pump coronary bypass. Asian Cardiovasc Thorac Ann. 2014 Jul; 22(6):674-81.
-
Prevalence of acute myocardial infarction in patients with presumably new left bundle-branch block. J Electrocardiol. 2012 Jul-Aug; 45(4):361-367.
-
Troponin criteria for myocardial infarction after percutaneous coronary intervention. Arch Intern Med. 2012 Mar 26; 172(6):502-8.
-
Prognostic implications of creatine kinase-MB elevation after percutaneous coronary intervention: results from the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry. Circ Cardiovasc Interv. 2011 Oct 01; 4(5):474-80.